93 related articles for article (PubMed ID: 19290408)
1. [Medical-surgical integrated approach in the treatment of non-paraneoplasic hyperparathyroidism: our experience].
Pulvirenti D; Campagna A; Ignaccolo L; Giustolisi N; Costa V
Clin Ter; 2009; 160(1):21-4. PubMed ID: 19290408
[TBL] [Abstract][Full Text] [Related]
2. [Medical-surgical integrated approach in the treatment of non-paraneoplasic hyperparathyroidism: our experience].
Pulvirenti D; Aikaterini T; Campagna A; Ignaccolo L; Giustolisi N; Costa E
Clin Ter; 2008; 159(5):307-10. PubMed ID: 18998031
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. [Surgical treatment of hyperparathyroidism].
Târcoveanu E; Niculescu D; Moldovanu R; Cotea E; Vasilescu A; Dănilă N; Lăzescu D; Ferariu D; Crumpei F; Ichim M; Zbranca E
Chirurgia (Bucur); 2009; 104(5):531-44. PubMed ID: 19943551
[TBL] [Abstract][Full Text] [Related]
5. [Surgical therapy concept in primary hyperparathyroidism].
Rusterholz D; Müller W
Schweiz Med Wochenschr Suppl; 2000; 116():62S-65S. PubMed ID: 10780075
[TBL] [Abstract][Full Text] [Related]
6. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery.
Räkel A; Brossard JH; Patenaude JV; Albert C; Nassif E; Cantor T; Rousseau L; D'Amour P
Clin Endocrinol (Oxf); 2005 Jun; 62(6):721-7. PubMed ID: 15943835
[TBL] [Abstract][Full Text] [Related]
7. Early intervention with intravenous or pulse oral vitamin D therapy is more effective in the treatment of secondary hyperparathyroidism.
Yamada S; Taniguchi M; Tokumoto M; Tsuruya K; Hirakata H; Iida M
Ther Apher Dial; 2010 Aug; 14(4):424-31. PubMed ID: 20649764
[TBL] [Abstract][Full Text] [Related]
8. Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism.
Beyer TD; Solorzano CC; Prinz RA; Babu A; Nilubol N; Patel S
Surgery; 2007 Jun; 141(6):777-83. PubMed ID: 17560254
[TBL] [Abstract][Full Text] [Related]
9. Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism.
Malberti F; Corradi B; Cosci P; Colecchia M; Leopardi O; Grossi L; Oldini C; Imbasciati E
Nephrol Dial Transplant; 1996 Jan; 11(1):81-7. PubMed ID: 8649657
[TBL] [Abstract][Full Text] [Related]
10. [A clinical study on active vitamin D pulse therapy in hemodialysis patients with secondary hyperparathyroidism].
Ehara H; Nezasa S; Hagiwara N; Yamada T; Yasuda M; Nishino Y; Nishida Y; Takahashi Y; Ishihara S; Deguchi T
Hinyokika Kiyo; 2000 Mar; 46(3):165-8. PubMed ID: 10806572
[TBL] [Abstract][Full Text] [Related]
11. In vivo studies of parathyroid gland function in secondary hyperparathyroidism.
Salusky IB; Goodman WG
Adv Nephrol Necker Hosp; 1996; 25():289-302. PubMed ID: 8717632
[TBL] [Abstract][Full Text] [Related]
12. Clinical profile and outcome of primary hyperparathyroidism accompanied by chronic renal failure.
Mizumoto D; Watanabe Y; Fukuzawa Y; Aoi N; Yamazaki C
Clin Nephrol; 1994 Nov; 42(5):315-21. PubMed ID: 7851033
[TBL] [Abstract][Full Text] [Related]
13. Post-parathyroidectomy hypocalcemia: incidence, risk factors, and management.
Mittendorf EA; Merlino JI; McHenry CR
Am Surg; 2004 Feb; 70(2):114-9; discussion 119-20. PubMed ID: 15011912
[TBL] [Abstract][Full Text] [Related]
14. RenaGel efficacy in severe secondary hyperparathyroidism.
Castro R; Herman A; Ferreira C; Travassos F; Nunes-Azevedo J; Oliveira M
Nefrologia; 2002; 22(5):448-55. PubMed ID: 12497746
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum parathormone level after "concise parathyroidectomy" for primary sporadic hyperparathyroidism.
Carty SE; Roberts MM; Virji MA; Haywood L; Yim JH
Surgery; 2002 Dec; 132(6):1086-92; discussion 1092-3. PubMed ID: 12490859
[TBL] [Abstract][Full Text] [Related]
16. A controlled trial of the early treatment of secondary hyperparathyroidism with calcitriol in hemodialysis patients.
Delmez JA; Kelber J; Norwood KY; Giles KS; Slatopolsky E
Clin Nephrol; 2000 Oct; 54(4):301-8. PubMed ID: 11076106
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome after total parathyroidectomy for the management of secondary hyperparathyroidism.
Stracke S; Keller F; Steinbach G; Henne-Bruns D; Wuerl P
Nephron Clin Pract; 2009; 111(2):c102-9. PubMed ID: 19142022
[TBL] [Abstract][Full Text] [Related]
18. Tertiary hyperparathyroidism: histologic patterns of disease and results of parathyroidectomy.
Kebebew E; Duh QY; Clark OH
Arch Surg; 2004 Sep; 139(9):974-7. PubMed ID: 15381615
[TBL] [Abstract][Full Text] [Related]
19. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism.
Rostaing L; Moreau-Gaudry X; Baron E; Cisterne JM; Monroziès-Bernadet P; Durand D
Clin Nephrol; 1997 Apr; 47(4):248-55. PubMed ID: 9128792
[TBL] [Abstract][Full Text] [Related]
20. Long-term control of parathyroid hormone and calcium-phosphate metabolism after parathyroidectomy in children with chronic kidney disease.
Schaefer B; Schlosser K; Wühl E; Schall P; Klaus G; Schaefer F; Schmitt CP
Nephrol Dial Transplant; 2010 Aug; 25(8):2590-5. PubMed ID: 20181803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
